WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

Observations placeholder

Invega

Identifier

001503

Type of Spiritual Experience

Hallucination

Number of hallucinations: 501

Background

A description of the experience

Paliperidone  - trade name Invega , also known as 9-hydroxyrisperidone, is an atypical antipsychotic.

Invega is an extended release formulation for once-daily dosing. Paliperidone palmitate (trade name Invega Sustenna named Xeplion in Europe and other countries) is a long-acting injectable formulation of paliperidone palmitoyl ester indicated for once-monthly injection. Chemically, paliperidone is one of many active metabolites of the older atypical antipsychotic risperidone . It is indicated for the acute and maintenance treatment of schizophrenia.

On May 18, 2015, a new formulation of paliperidone palmitate was approved by the FDA under the brand name Invega Trinza. A similar 3 -monthly injection of prolonged release suspension was approved in 2016 by the European Medicines Agency originally under the brand name Paliperidone Janssen, later renamed to Trevicta.

On Jan, 16, 2017 14,925 people reported to have side effects when taking Invega.  Among them, 78 people (0.52%) have Hallucination

On Jan, 27, 2017 14,925 people reported to have side effects when taking Invega.  Among them, 113 people (0.76%) have Hallucination, Auditory

On Jan, 26, 2017 8,979 people reported to have side effects when taking Invega Sustenna.  Among them, 185 people (2.06%) have Hallucination, Auditory

On Jan, 10, 2017 8,979 people reported to have side effects when taking Invega Sustenna.  Among them, 111 people (1.24%) have Hallucination

On Jan, 19, 2017 275 people reported to have side effects when taking Invega Trinza.  Among them, 14 people (5.09%) have Sensory Hallucinations

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

Hearing voices

References